Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-31

Clinical Trial Update: Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating recombinant von Willebrand factor in patients with severe von Willebrand disease undergoing surgery has completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • recombinant von Willebrand factor (recombinant von Willebrand factor)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Von Willebrand Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-08-31